Difference between revisions of "WSI23-111-Case-16"
From MGH Learn Pathology
(Added status template) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 12: | Line 12: | ||
|sequence=16 | |sequence=16 | ||
|performer=RMN6 | |performer=RMN6 | ||
| − | |reasonCode=Case #16 - The patient is a 55-year-old male with past medical history significant for antiphospholipid antibody syndrome (APLS) with multiple pulmonary emboli and deep vein thromboses now on coumadin, type I diabetes mellitus complicated by end-stage renal disease requiring Monday-Wednesday-Friday hemodialysis. He has had a chronic lower extremity ulcer for the past 4 years in the setting of pressure related trauma secondary to wheelchair dependence. Relevant laboratory results: Creatinine 6.72 mg/dL (reference interval 0.6-1.50 mg/dL), calcium 9.3 mg/dL (reference interval 8.5-10.5 mg/dL), phosphate 2.9 mg/dL (reference interval 2.6-4.5 mg/dL), PTH 81 pg/mL (reference interval 10-60 pg/mL). On exam, he has a chronic non-healing lesion with no evidence of retiform purpura, no induration and without exquisite tenderness (see clinical photograph #16 | + | |reasonCode=Case #16 - The patient is a 55-year-old male with past medical history significant for antiphospholipid antibody syndrome (APLS) with multiple pulmonary emboli and deep vein thromboses now on coumadin, type I diabetes mellitus complicated by end-stage renal disease requiring Monday-Wednesday-Friday hemodialysis. He has had a chronic lower extremity ulcer for the past 4 years in the setting of pressure related trauma secondary to wheelchair dependence. Relevant laboratory results: Creatinine 6.72 mg/dL (reference interval 0.6-1.50 mg/dL), calcium 9.3 mg/dL (reference interval 8.5-10.5 mg/dL), phosphate 2.9 mg/dL (reference interval 2.6-4.5 mg/dL), PTH 81 pg/mL (reference interval 10-60 pg/mL). On exam, he has a chronic non-healing lesion with no evidence of retiform purpura, no induration and without exquisite tenderness (see clinical photograph #16). A punch biopsy is obtained from the edge of the lesion. |
|supportingInfo=16 | |supportingInfo=16 | ||
}} | }} | ||
| Line 36: | Line 36: | ||
|modality=mrxs | |modality=mrxs | ||
|identifier=deee4931-6af7-43e3-b54d-71cb2a9e0d8d | |identifier=deee4931-6af7-43e3-b54d-71cb2a9e0d8d | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Em99 | ||
| + | |authoredOn=August 03, 2023 11:10:18 AM | ||
}} | }} | ||
Latest revision as of 15:43, December 9, 2024
